InvestorsHub Logo
Followers 15
Posts 1189
Boards Moderated 1
Alias Born 12/31/2008

Re: None

Wednesday, 02/12/2014 7:50:06 AM

Wednesday, February 12, 2014 7:50:06 AM

Post# of 6939
ETRM - ADCOM Meeting - May 29

EnteroMedics Announces Food and Drug Administration Advisory Committee Meeting Date for Review of the Maestro(R) Rechargeable System for the Treatment of Obesity

link: http://finance.yahoo.com/news/enteromedics-announces-food-drug-administration-120000694.html


Center for Devices and Radiologic Health Advisory Committee Scheduled for May 29, 2014

ST. PAUL, MN--(Marketwired - Feb 12, 2014) - EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the U.S. Food and Drug Administration's Office of Device Evaluation has scheduled a meeting of the Center for Devices and Radiologic Health's (CDRH) Advisory Committee on Thursday, May 29, 2014 to review the Maestro® System delivering VBLOC® vagal blocking therapy as a treatment for morbid obesity. The CDRH Advisory Committee is an independent panel of clinical and scientific experts that helps evaluate medical devices for safety and efficacy and makes recommendations regarding Benefit-Risk to the FDA.

more on the link... http://finance.yahoo.com/news/enteromedics-announces-food-drug-administration-120000694.html

These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.